2 October 2026
Linklaters advises Fresenius on the full acquisition of the biopharmaceutical company mAbxience
Advising firms
Deal team
17 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Dr Ralph Wollburg Lead | Linklaters | Partner | Corporate/M&A | Not stated |
| Arne Kießling | Linklaters | Partner | Corporate/M&A | Not stated |
| Esteban Arza | Linklaters | Partner | Corporate/M&A | Not stated |
| Michael Leicht | Linklaters | Partner | TMT IP | Not stated |
| Dr Jana Hager | Linklaters | Partner | Corporate/M&A | Not stated |
| Fredrik Lowhagen | Linklaters | Partner | Antitrust | Not stated |
| Borja Fernandez de Troconiz | Linklaters | Partner | Litigation | Not stated |
| Beatriz Melo | Linklaters | Senior associate | Corporate/M&A | Not stated |
| Jose Buigues | Linklaters | Senior associate | Corporate/M&A | Not stated |
| Rana Ersoy | Linklaters | Senior associate | Corporate/M&A | Not stated |
| Antonia Mertens | Linklaters | Associate | TMT IP | Not stated |
| Marc Heusel | Linklaters | Associate | TMT IP | Not stated |
| Inés Alfaro | Linklaters | Associate | Corporate/M&A | Not stated |
| Sofia Rubio | Linklaters | Associate | Corporate/M&A | Not stated |
| Alba Gubia | Linklaters | Associate | Antitrust | Not stated |
| Maria Angeles Lara | Linklaters | Associate | Corporate/M&A | Not stated |
| Teresa Hermosilla | Linklaters | Associate | Litigation | Not stated |
14 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- EUR 750m (EUR 750 million)
- What the figure measures
- Total transaction value
- Client
- FreseniusBuy-side
- Counterparties
- mAbxience (Sell-side)